Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience.

PubWeight™: 1.96‹?› | Rank: Top 2%

🔗 View Article (PMID 11597807)

Published in Int J Radiat Oncol Biol Phys on November 01, 2001

Authors

M Uematsu1, A Shioda, A Suda, T Fukui, Y Ozeki, Y Hama, J R Wong, S Kusano

Author Affiliations

1: Department of Radiation Oncology, National Defense Medical College, Tokorozawa, Saitama, Japan. uematsu@me.ndmc.ac.jp

Articles citing this

A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927). Int J Radiat Oncol Biol Phys (2015) 1.88

Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol (2009) 1.76

A survey of stereotactic body radiotherapy use in the United States. Cancer (2011) 1.71

Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors. Radiat Oncol (2007) 1.70

Is radiofrequency ablation or stereotactic ablative radiotherapy the best treatment for radically treatable primary lung cancer unfit for surgery? Interact Cardiovasc Thorac Surg (2012) 1.17

Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors. Int J Clin Oncol (2007) 1.11

Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size. Radiat Oncol (2010) 1.08

CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment. J Hematol Oncol (2010) 1.08

Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy. Radiat Oncol (2010) 1.07

Radiation therapy dose escalation for prostate cancer: a rationale for IMRT. World J Urol (2003) 1.06

Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases. Radiat Oncol (2006) 1.02

Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer. Radiat Oncol (2013) 0.99

Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours. Br J Radiol (2012) 0.96

Rib fracture after stereotactic radiotherapy on follow-up thin-section computed tomography in 177 primary lung cancer patients. Radiat Oncol (2011) 0.96

Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT). Radiat Oncol (2013) 0.95

An evaluation of planning techniques for stereotactic body radiation therapy in lung tumors. Radiother Oncol (2008) 0.94

Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results. Radiat Oncol (2009) 0.93

CyberKnife for hilar lung tumors: report of clinical response and toxicity. J Hematol Oncol (2010) 0.91

Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases: final report of a prospective clinical trial. Target Oncol (2013) 0.91

Current status of stereotactic body radiotherapy for lung cancer. Int J Clin Oncol (2007) 0.91

Endovascular coils as lung tumour markers in real-time tumour tracking stereotactic radiotherapy: preliminary results. Eur Radiol (2008) 0.87

Comparison of therapeutic results from radiofrequency ablation and stereotactic body radiotherapy in solitary lung tumors measuring 5 cm or smaller. Int J Clin Oncol (2014) 0.86

Stereotactic body radiotherapy for early stage lung cancer. Cancer Res Treat (2013) 0.83

Is surgery still the optimal treatment for stage I non-small cell lung cancer? Transl Lung Cancer Res (2016) 0.83

Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors: first results of a phase I/II study. Strahlenther Onkol (2006) 0.82

Complications from Stereotactic Body Radiotherapy for Lung Cancer. Cancers (Basel) (2015) 0.82

A method for improved verification of entire IMRT plans by film dosimetry. Strahlenther Onkol (2009) 0.81

Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size. Radiat Oncol (2015) 0.79

Prognostic impact of average iodine density assessed by dual-energy spectral imaging for predicting lung tumor recurrence after stereotactic body radiotherapy. J Radiat Res (2016) 0.79

Do we have enough evidence to implement particle therapy as standard treatment in lung cancer? A systematic literature review. Oncologist (2010) 0.79

Clinical outcome of stereotactic body radiotherapy for primary and oligometastatic lung tumors: a single institutional study with almost uniform dose with different five treatment schedules. Radiat Oncol (2016) 0.78

Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors. J Radiat Res (2012) 0.78

Stereotactic body radiotherapy for small lung tumors in the University of Tokyo Hospital. Biomed Res Int (2014) 0.78

Towards a noninvasive intracranial tumor irradiation using 3d optical imaging and multimodal data registration. Int J Biomed Imaging (2007) 0.78

Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy? Transl Lung Cancer Res (2012) 0.78

Intrafractional setup errors in patients undergoing non-invasive fixation using an immobilization system during hypofractionated stereotactic radiotherapy for lung tumors. J Radiat Res (2013) 0.77

Integral dose and radiation-induced secondary malignancies: comparison between stereotactic body radiation therapy and three-dimensional conformal radiotherapy. Int J Environ Res Public Health (2012) 0.77

Stereotactic body radiation therapy is effective and safe in patients with early-stage non-small cell lung cancer with low performance status and severe comorbidity. Case Rep Oncol (2011) 0.77

Effect of histologic type on recurrence pattern in radiation therapy for medically inoperable patients with stage I non-small-cell lung cancer. Lung (2006) 0.77

Magnitude of shift of tumor position as a function of moderated deep inspiration breath-hold: An analysis of pooled data of lung patients with active breath control in image-guided radiotherapy. J Med Phys (2008) 0.77

Results of a preliminary study using hypofractionated involved-field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced non-small-cell lung cancer. Int J Clin Oncol (2009) 0.76

Scalpel or SABR for Treatment of Early-Stage Lung Cancer: Clinical Considerations for the Multidisciplinary Team. Cancers (Basel) (2011) 0.75

SBRT versus lobectomy in stage I NSCLC: knowns, unknowns and its interpretation. J Thorac Dis (2016) 0.75

Excessive Soft Tissue Reaction after Stereotactic Body Radiation Therapy in a Woman with Four Different Cancer Diagnoses. Case Rep Oncol (2010) 0.75

SBRT in operable early stage lung cancer patients. Transl Lung Cancer Res (2014) 0.75

Adenovirus-mediated Foxp3 expression in lung epithelial cells ameliorates acute radiation-induced pneumonitis in mice. Gene Ther (2016) 0.75

Comorbidity-adjusted survival in early stage lung cancer patients treated with hypofractionated proton therapy. J Oncol (2010) 0.75

Patient outcomes of monotherapy with hypofractionated three-dimensional conformal radiation therapy for stage T2 or T3 non-small cell lung cancer: a retrospective study. Radiat Oncol (2016) 0.75

Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens. Oncologist (2016) 0.75

The war on cancer: a report from the front lines. Proc (Bayl Univ Med Cent) (2006) 0.75

Articles by these authors

Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). Biochem Biophys Res Commun (1989) 3.09

Localization of endoplasmic reticulum in living and glutaraldehyde-fixed cells with fluorescent dyes. Cell (1984) 2.73

p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem (1996) 2.56

Nucleotide sequence of the PR-1 gene of Nicotiana tabacum. FEBS Lett (1987) 2.53

An extracellular poly(3-hydroxybutyrate) depolymerase from Alcaligenes faecalis. Eur J Biochem (1982) 2.49

Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep (2001) 2.43

An N-linked high-mannose type oligosaccharide, expressed at the major outer membrane protein of Chlamydia trachomatis, mediates attachment and infectivity of the microorganism to HeLa cells. J Clin Invest (1996) 2.35

Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. J Biol Chem (1985) 2.18

Centromere-linkage analysis and consolidation of the zebrafish genetic map. Genetics (1996) 2.15

Polyphosphoinositides produced by phosphatidylinositol 3-kinase are poor substrates for phospholipases C from rat liver and bovine brain. J Biol Chem (1989) 2.15

Cloning and characterization of the cDNAs for human and rabbit interleukin-1 precursor. Nucleic Acids Res (1985) 2.06

Classification and Structural Comparison of Full-Length cDNAs for Pathogenesis-Related Proteins. Plant Physiol (1987) 2.06

Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res (1998) 2.02

Selectivity of the Escherichia coli RNA polymerase E sigma 38 for overlapping promoters and ability to support CRP activation. Nucleic Acids Res (1995) 1.98

Purification and properties of an auxin-binding protein from maize shoot membranes. J Biochem (1986) 1.97

Complete nucleotide sequence of the gene for human interleukin 1 alpha. Nucleic Acids Res (1986) 1.95

Biosynthesis of 50 s ribosomal subunit in Escherichia coli. J Mol Biol (1969) 1.89

Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation. J Clin Microbiol (2000) 1.80

Auxin-binding protein located in the endoplasmic reticulum of maize shoots: molecular cloning and complete primary structure. Proc Natl Acad Sci U S A (1989) 1.77

Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis (2001) 1.69

An immunohistochemical study of developing glomeruli in human fetal kidneys. Kidney Int (2000) 1.69

Critical review of 'Public domain application': a flexible drug approval system in Japan. Ann Oncol (2013) 1.65

Amino acid sequence of mammalian elongation factor 2 deduced from the cDNA sequence: homology with GTP-binding proteins. Proc Natl Acad Sci U S A (1986) 1.64

Effective "short" double-balloon enteroscope for diagnostic and therapeutic ERCP in patients with altered gastrointestinal anatomy: a large case series. Endoscopy (2009) 1.61

Doctor-shopping patients and users of alternative medicine among Japanese primary care patients. Gen Hosp Psychiatry (1995) 1.60

Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer (1997) 1.60

Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer (1998) 1.58

Purification and properties of extracellular poly(3-hydroxybutyrate) depolymerases from Pseudomonas lemoignei. Biochim Biophys Acta (1985) 1.58

A unique chitinase with dual active sites and triple substrate binding sites from the hyperthermophilic archaeon Pyrococcus kodakaraensis KOD1. Appl Environ Microbiol (1999) 1.56

Enzymatic synthesis of poly-beta-hydroxybutyrate in Zoogloea ramigera. Arch Microbiol (1976) 1.54

Cloning, nucleotide sequence, and expression in Escherichia coli of the gene for poly(3-hydroxybutyrate) depolymerase from Alcaligenes faecalis. J Bacteriol (1989) 1.54

First case of Pasteurella gallinarum isolation from blood of a patient with symptoms of acute gastroenteritis in Japan. Clin Infect Dis (1999) 1.52

Hepatic inferior vena cava obstruction: treatment of two types with Gianturco expandable metallic stents. Radiology (1990) 1.51

Alpha-glucan phosphorylase from Escherichia coli. Cloning of the gene, and purification and characterization of the protein. J Biol Chem (1988) 1.50

Borrelia sinica sp. nov., a lyme disease-related Borrelia species isolated in China. Int J Syst Evol Microbiol (2001) 1.50

Use of contrast-enhanced computed tomography to measure clearance per unit renal volume: a novel measurement of renal function and fractional vascular volume. Am J Kidney Dis (1999) 1.49

Production and characterization of recombinant human neutrophil chemotactic factor. J Biochem (1989) 1.47

Multidrug resistance-associated protein (MRP) expression is correlated with expression of aberrant p53 protein in colorectal cancer. Eur J Cancer (1999) 1.46

Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan. J Med Screen (2004) 1.45

Biosynthetic thiolase from zoogloea ramigera. I. Preliminary characterization and analysis of proton transfer reaction. J Biol Chem (1987) 1.44

Protruding atherosclerotic aortic plaques and dyslipidaemia: correlation to subtypes of ischaemic stroke. Eur J Echocardiogr (2002) 1.43

Reanalysis of unruptured intracranial aneurysm management: effect of a new international study on the threshold probabilities. Med Decis Making (2001) 1.42

Promoter determinants for Escherichia coli RNA polymerase holoenzyme containing sigma 38 (the rpoS gene product). Nucleic Acids Res (1995) 1.42

Guide-wire-directed detachable balloon: clinical application in treatment of varicoceles. Radiology (1992) 1.41

Comparative glucan specificities of two types of spinach leaf phosphorylase. J Biochem (1982) 1.41

A novel mutation in the vasopressin V2 receptor gene in a woman with congenital nephrogenic diabetes insipidus. Intern Med (1999) 1.40

Inhibitory effect of cephalothin on matrix metalloproteinase activity around loose hip prostheses. Antimicrob Agents Chemother (1996) 1.40

Successful transcatheter embolization of penetrating aortic ulcer using interlocking detachable coils. Cardiovasc Intervent Radiol (2001) 1.40

Research output in anaesthesia: a quantitative ranking. Anaesthesia (2002) 1.39

Comparing postgraduate medical education at university and non-university hospitals in Japan. Acad Med (1992) 1.39

Cloning and molecular analysis of the Poly(3-hydroxybutyrate) and Poly(3-hydroxybutyrate-co-3-hydroxyalkanoate) biosynthesis genes in Pseudomonas sp. strain 61-3. J Bacteriol (1998) 1.38

Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer (1998) 1.37

Prostaglandin E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5. J Immunol (1995) 1.36

Knowledge, attitudes, beliefs and practices about HIV/AIDS among the overseas job seekers in Bangladesh. Public Health (1999) 1.36

Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin. Stroke (2000) 1.31

Promoter selectivity of Escherichia coli RNA polymerase sigmaF holoenzyme involved in transcription of flagellar and chemotaxis genes. J Bacteriol (1997) 1.30

Identification of lysine 15 at the active site in Escherichia coli glycogen synthase. Conservation of Lys-X-Gly-Gly sequence in the bacterial and mammalian enzymes. J Biol Chem (1990) 1.29

Promoter selectivity control of Escherichia coli RNA polymerase by ionic strength: differential recognition of osmoregulated promoters by E sigma D and E sigma S holoenzymes. Mol Microbiol (1995) 1.28

Primary structure of maize pyruvate, orthophosphate dikinase as deduced from cDNA sequence. J Biol Chem (1988) 1.26

Structure and some characterization of the gene for phenylalanine ammonia-lyase from rice plants. Eur J Biochem (1989) 1.26

Structure and characterization of a cDNA clone for phenylalanine ammonia-lyase from cut-injured roots of sweet potato. Plant Physiol (1989) 1.25

Polynucleotides. XL. Synthesis and properties of poly 2'-azido-2'-deoxyadenylic acid. Nucleic Acids Res (1976) 1.25

Different cleavage specificities of the dual catalytic domains in chitinase from the hyperthermophilic archaeon Thermococcus kodakaraensis KOD1. J Biol Chem (2001) 1.25

Generation of the topa quinone cofactor in bacterial monoamine oxidase by cupric ion-dependent autooxidation of a specific tyrosyl residue. FEBS Lett (1994) 1.24

A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res (1996) 1.23

Minimum light intensity required to suppress nocturnal melatonin concentration in human saliva. Neurosci Lett (1998) 1.22

Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer. J Natl Cancer Inst (2001) 1.21

Purification and properties of D(-)-3-hydroxybutyrate-dimer hydrolase from Zoogloea ramigera I-16-M. Eur J Biochem (1981) 1.20

Plasma immunoreactive endothelin in essential hypertension. Am J Med (1990) 1.20

Degradation of poly(3-hydroxybutyrate) by poly(3-hydroxybutyrate) depolymerase from Alcaligenes faecalis T1. Biochim Biophys Acta (1986) 1.19

Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients. Clin Pharmacol Ther (2010) 1.19

Nucleotide sequence of cDNA encoding the small subunit of ribulose-1,5-bisphosphate carboxylase from maize. J Biochem (1987) 1.18

Effect of rifampicin and CYP2B6 genotype on long-term efavirenz autoinduction and plasma exposure in HIV patients with or without tuberculosis. Clin Pharmacol Ther (2011) 1.15

Malignant schwannoma of the esophagus with lymph node metastasis: literature review of schwannoma of the esophagus. J Gastroenterol (2001) 1.14

UDP-glucose pyrophosphorylase from potato tuber: cDNA cloning and sequencing. J Biochem (1990) 1.14

Determination of members of a Borrelia afzelii-related group isolated from Ixodes nipponensis in Korea as Borrelia valaisiana. Int J Syst Bacteriol (1999) 1.14

A new affinity labeling reagent for the active site of glycogen synthase. Uridine diphosphopyridoxal. J Biol Chem (1985) 1.14

Role of the conserved Lys-X-Gly-Gly sequence at the ADP-glucose-binding site in Escherichia coli glycogen synthase. J Biol Chem (1993) 1.13

Biosynthesis of poly(3-hydroxybutyrate-co-3-hydroxyalkanoates) by recombinant bacteria expressing the PHA synthase gene phaC1 from Pseudomonas sp. 61-3. Appl Microbiol Biotechnol (2000) 1.13

Polynucleotides. XLV Synthesis and properties of poly(2'-azido-2'-deoxyinosinic acid). Nucleic Acids Res (1977) 1.13

Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population. Jpn J Cancer Res (1999) 1.13

Cloning of the Escherichia coli gene for the stringent starvation protein. Mol Gen Genet (1985) 1.13

Potato and rabbit muscle phosphorylases: comparative studies on the structure, function and regulation of regulatory and nonregulatory enzymes. Mol Cell Biochem (1982) 1.13

Mechanism for transcriptional action of cyclic AMP in Escherichia coli: entry into DNA to disrupt DNA secondary structure. Proc Natl Acad Sci U S A (1981) 1.13

Survey of Japanese physicians' attitudes towards the care of adult patients in persistent vegetative state. J Med Ethics (1999) 1.13

Molecular cloning and the complete nucleotide sequence of cDNA to mRNA for S-100 protein of rat brain. Nucleic Acids Res (1984) 1.12

ATP-citrate lyase from the green sulfur bacterium Chlorobium limicola is a heteromeric enzyme composed of two distinct gene products. Eur J Biochem (2001) 1.10

UDP-glucose pyrophosphorylase from potato tuber: purification and characterization. J Biochem (1989) 1.10

Primary structure of hemorrhagic protein, HR2a, isolated from the venom of Trimeresurus flavoviridis. J Biochem (1989) 1.10

CT evaluation of hepatic tumors: comparison of CT with arterial portography, CT with infusion hepatic arteriography, and simultaneous use of both techniques. AJR Am J Roentgenol (1995) 1.09

Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer. Br J Cancer (1999) 1.09

The complete amino acid sequence of potato alpha-glucan phosphorylase. J Biol Chem (1986) 1.08

Serine racemase binds to PICK1: potential relevance to schizophrenia. Mol Psychiatry (2006) 1.08

Polynucleotides. LII. Synthesis and properties of poly(2'-deoxy-2'-fluoroadenylic acid). Nucleic Acids Res (1978) 1.08

Co-expression of 3-ketoacyl-ACP reductase and polyhydroxyalkanoate synthase genes induces PHA production in Escherichia coli HB101 strain. FEMS Microbiol Lett (1999) 1.08

Crystal structure of a novel-type archaeal rubisco with pentagonal symmetry. Structure (2001) 1.07

Purification and characterization of NADP-linked acetoacetyl-CoA reductase from Zoogloea ramigera I-16-M. Biochim Biophys Acta (1987) 1.07